114
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluation

Toremifene – a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy

, , , , , & show all
Pages 293-305 | Published online: 27 Feb 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kashif Siddiqui & Laurence H Klotz. (2009) Emerging drugs for prostate cancer. Expert Opinion on Emerging Drugs 14:3, pages 455-470.
Read now

Articles from other publishers (20)

Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer 161 204 .
Qing Wu, Wei Qian, Xiaoli Sun & Shaojie Jiang. (2022) Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021. Journal of Hematology & Oncology 15:1.
Crossref
Jaqueline S. da Silva, Tadeu L. Montagnoli, Bruna S. Rocha, Matheus L. C. A. Tacco, Sophia C. P. Marinho & Gisele Zapata-Sudo. (2021) Estrogen Receptors: Therapeutic Perspectives for the Treatment of Cardiac Dysfunction after Myocardial Infarction. International Journal of Molecular Sciences 22:2, pages 525.
Crossref
Tetsuya Fujimura, Kenichi Takayama, Satoru Takahashi & Satoshi Inoue. (2018) Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine. Cancers 10:2, pages 29.
Crossref
Tetsuya Fujimura, Satoru Takahashi, Haruki Kume, Tomohiko Urano, Kenichi Takayama, Yuta Yamada, Motofumi Suzuki, Hiroshi Fukuhara, Tohru Nakagawa, Satoshi Inoue & Yukio Homma. (2015) Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial. BMC Cancer 15:1.
Crossref
Samy A.F. Morad & Myles C. Cabot. (2015) Tamoxifen regulation of sphingolipid metabolism—Therapeutic implications. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1851:9, pages 1134-1145.
Crossref
N. Delattin, K. De Brucker, K. Vandamme, E. Meert, A. Marchand, P. Chaltin, B. P. A. Cammue & K. Thevissen. (2013) Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms. Journal of Antimicrobial Chemotherapy 69:4, pages 1035-1044.
Crossref
Samy A.F. Morad, Jonathan C. Levin, Su-Fern Tan, Todd E. Fox, David J. Feith & Myles C. Cabot. (2013) Novel off-target effect of tamoxifen ? Inhibition of acid ceramidase activity in cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1831:12, pages 1657-1664.
Crossref
Samir S. TanejaRonald MortonGary BarnettePaul SieberMichael L. HancockMitchell Steiner. (2013) Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene. Journal of Clinical Oncology 31:5, pages 523-529.
Crossref
Krishna Ramaswamy, Herbert Lepor & Samir S. Taneja. 2013. Prostate Cancer Diagnosis. Prostate Cancer Diagnosis 241 254 .
Shayne Cox GadGregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Shuk-Mei Ho, Ming-Tsung Lee, Hung-Ming Lam & Yuet-Kin Leung. (2011) Estrogens and Prostate Cancer: Etiology, Mediators, Prevention, and Management. Endocrinology and Metabolism Clinics of North America 40:3, pages 591-614.
Crossref
James H. Pickar, Tanya MacNeil & Kathleen Ohleth. (2010) SERMs: Progress and future perspectives. Maturitas 67:2, pages 129-138.
Crossref
Gregory Clines & Lauren A Kingsley. (2008) Novel targets for and mechanisms of bone metastasis: Meeting report from skeletal complications of malignancy V. IBMS BoneKEy 5:8, pages 297-301.
Crossref
Wendy Shelly, Michael W. Draper, Venkatesh Krishnan, Mayme Wong & Robert B. Jaffe. (2008) Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings. Obstetrical & Gynecological Survey 63:3, pages 163-181.
Crossref
David G. Bostwick, Junqi Qian & Deloar Hossain. 2008. Urologic Surgical Pathology. Urologic Surgical Pathology 380 440 .
Henry U. Bryant. 2008. Principles of Bone Biology. Principles of Bone Biology 887 919 .
M. Dror Michaelson, Donald S. Kaufman, Hang Lee, Francis J. McGovern, Philip W. Kantoff, Mary Anne Fallon, Joel S. Finkelstein & Matthew R. Smith. (2007) Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate Cancer. Journal of Clinical Oncology 25:9, pages 1038-1042.
Crossref
Leonard G. Gomella. (2007) Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues. BJU International 99:s1, pages 25-29.
Crossref
Neil Fleshner & Girish Kulkarni. (2006) Should finasteride be used to prevent prostate cancer?. Current Treatment Options in Oncology 7:5, pages 346-354.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.